Insiders · Profile

Bellini Roberto

Director at Inhibikase Therapeutics. Filing since 21 Oct 2024. CIK 0001802453

Company

Date

Role

Action

Shares

Amount

Of holding

IKT Inhibikase Therapeutics, Inc.

21 Oct 2024

Director

Bought

1,460,000

$2.00M

opened

1 decision on file.